Top Markets
Coin of the day
Poolbeg Pharma PLC Poolbeg Pharma PLC

Poolbeg Pharma PLC

POLB
Ранг среди акций #38627
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the... Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.
Цена акции
$0.11565963
Рыночная капитализация
$882.99K
Изменение (1 день)
-2.30%
Изменение (1 год)
189.81%
Страна
GB
Торговля Poolbeg Pharma PLC (POLB)

Категория

История цены акций Poolbeg Pharma PLC (POLB)
Наивысшая цена закрытия: $0.12 2026-08-01

Наименьшая цена закрытия: $0.15 2021-07-01
История цены акций Poolbeg Pharma PLC с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 28.20%
2025 -42.87%
2024 -20.84%
2023 32.33%
2022 -27.62%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$507.32 29.98%
US
$848.39 30.04%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE